Results 211 to 220 of about 819,681 (335)

Chemoprevention of Intestinal Polyps in ApcMin/+ Mice Fed with Western or Balanced Diets by Drinking Annurca Apple Polyphenol Extract

Cancer Prevention Research, 2011
L. Fini, L. Fini, G. Piazzi, G. Piazzi, Yahya Daoud, M. Selgrad, S. Maegawa, Melissa Garcia, V. Fogliano, M. Romano, G. Graziani, P. Vitaglione, Susanne W. Carmack, A. Gasbarrini, R. Genta, J. Issa, C. Boland, L. Ricciardiello, L. Ricciardiello   +18 more
semanticscholar   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage

, 2014
Sagen Zac-Verghese, Stefan Trapp, Paul Richards, Sophie R. Sayers, Gao Sun, Stephen R. Bloom, Frank Reimann, Fiona M. Gribble, Guy A. Rutter   +8 more
openalex   +1 more source

Overexpression of low‐density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice

International Journal of Cancer, 2009
M. Mutoh, Masami Komiya, N. Teraoka, Toshiya Ueno, Mami Takahashi, Tsukasa Kitahashi, T. Sugimura, K. Wakabayashi   +7 more
semanticscholar   +1 more source

IDDF2019-ABS-0226 The potential intestinal fungal biomarkers in patients with colonic polyps [PDF]

, 2019
Qiongyun Chen, Bangzhou Zhang, Hongzhi Xu, Jianlin Ren, Xiang Zhang   +4 more
openalex   +1 more source

Figure S3 from Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden

, 2023
David C. Montrose, Xi Kathy Zhou, Erin M. McNally, Erika Sue, Rhonda K. Yantiss, Steven S. Gross, Nitai D. Leve, Edward D. Karoly, Chen S. Suen, Lilan Ling, Robert Benezra, Eric G. Pamer, Andrew J. Dannenberg   +12 more
openalex   +1 more source

Su1252 ENDOSCOPIC TREATMENT OF LARGE POLYPS WITH ADRENALINE INJECTION VOLUME REDUCTION TECHNIQUE IN PATIENTS WITH PEUTZ-JEGHERS SYNDROME COMPLICATED WITH INTESTINAL OBSTRUCTION [PDF]

, 2018
Jorge Landaeta, Carla M. Dias, Virginia Armas, O Tempestini   +3 more
openalex   +1 more source

Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR

, 2021
Carolina Mantilla Rojas, Michael P. McGill, Anna C. Salvador, David J. Bautz, David W. Threadgill   +4 more
openalex   +2 more sources

5-Lipoxygenase Deficiency Diminishes TH2 Cell, Regulatory T-Cell and Dendritic Cell Infiltration of Murine Intestinal Polyps

, 2011
Joseph D. Phillips, Mohammad W. Khan, Eric C. Cheon, Paul J. Grippo, Khashayarsha Khazaie, David J. Bentrem   +5 more
openalex   +1 more source

Suppression of Intestinal Polyp Development by Nimesulide, a Selective Cyclooxygenase‐2 Inhibitor, in Min Mice [PDF]

, 1997
Seiichi Nakatsugi, Masato Fukutake, Mami Takahashi, Kazunori Fukuda, T Isoi, Yasuaki Taniguchi, Takashi Sügimura, Keiji Wakabayashi   +7 more
openalex   +1 more source